| Neuraxpharm Switzerland AG - Tranxilium 5, Hartkapseln |
| 33866 | | 01 | | Tranxilium 5 | | Hartkapseln | | N05BA05 | | Dikaliumclorazepat | | 14.06.1971 | | |
|
| Composition |
| dikalii clorazepas 5 mg, kalii carbonas, talcum, Kapselhülle: gelatina, E 127, E 171, pro capsula. |
| Packungsbestandteile |
| Capsules | | | | | Principe actif | Concentr. |
|---|
| Clorazepat-Dikalium | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Clorazepat-Dikalium | 5 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| E 127 | | color. | | E 171 | | color. | | Gelatina | | Kapselhülle | | Potassium Carbonate | | | | Pro Capsula | | | | Talcum | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 071 | 20 Gélule(s) | 1.86 | 11.25 | B | LS | Non | | 072 | 50 Gélule(s) | 3.33 | 12.85 | B | LS | Non |
|
